PMC:7247521 / 991-1269 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"29","span":{"begin":157,"end":163},"obj":"Gene"},{"id":"30","span":{"begin":174,"end":178},"obj":"Gene"},{"id":"31","span":{"begin":265,"end":269},"obj":"Gene"},{"id":"40","span":{"begin":51,"end":63},"obj":"Disease"},{"id":"41","span":{"begin":73,"end":94},"obj":"Disease"},{"id":"42","span":{"begin":96,"end":102},"obj":"Disease"},{"id":"43","span":{"begin":104,"end":141},"obj":"Disease"},{"id":"44","span":{"begin":251,"end":260},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Gene:406959"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Gene:1022"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Gene:59272"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:D003141"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D007249"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D001249"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D029424"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"g pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expre"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T23","span":{"begin":124,"end":133},"obj":"UBERON:0002048"},{"id":"T24","span":{"begin":150,"end":155},"obj":"SO:0000276"},{"id":"T25","span":{"begin":174,"end":178},"obj":"PR:000005265"},{"id":"T26","span":{"begin":265,"end":269},"obj":"G_3;PG_10;PR:000003622"}],"text":"g pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expre"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T6","span":{"begin":73,"end":94},"obj":"Disease"},{"id":"T7","span":{"begin":96,"end":102},"obj":"Disease"},{"id":"T8","span":{"begin":104,"end":141},"obj":"Disease"},{"id":"T9","span":{"begin":251,"end":260},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"g pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expre"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":25,"end":34},"obj":"http://purl.obolibrary.org/obo/SO_0000418"}],"text":"g pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expre"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":51,"end":54},"obj":"Chemical"},{"id":"T5","span":{"begin":184,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_73659"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_74862"}],"text":"g pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expre"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":96,"end":102},"obj":"Phenotype"},{"id":"T2","span":{"begin":104,"end":141},"obj":"Phenotype"},{"id":"T3","span":{"begin":251,"end":260},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"g pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expre"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T10","span":{"begin":11,"end":42},"obj":"http://purl.obolibrary.org/obo/GO_0033211"},{"id":"T11","span":{"begin":11,"end":42},"obj":"http://purl.obolibrary.org/obo/GO_0033210"},{"id":"T12","span":{"begin":11,"end":42},"obj":"http://purl.obolibrary.org/obo/GO_0033209"},{"id":"T13","span":{"begin":25,"end":42},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T14","span":{"begin":25,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T15","span":{"begin":184,"end":186},"obj":"http://purl.obolibrary.org/obo/GO_0000981"}],"text":"g pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expre"}